CCRM
Share
CCRM (legally, the Centre for Commercialization of Regenerative Medicine) is a unique not-for-profit group that supports the development and commercialization of regenerative medicines and associated enabling technologies, with a specific focus on cell and gene therapy. In 2016 we received $20M from the Government of Canada and a matching $20M from GE Healthcare to establish a centre for advanced
06/09/2026
Michael May, CCRM's President and CEO, reflects on what motivated and inspired him to establish CCRM 15 years ago with co-founder Peter Zandstra, what they have accomplished together, and the opportunities ahead.
Today, companies like BlueRock Therapeutics, Notch Therapeutics and ExCellThera demonstrate what's possible when great science is matched with the right infrastructure and partnerships. And with initiatives like and DeepTech Bio Lab™, CCRM is helping position Canada at the forefront of the next generation of biotechnology innovation.
As per Dr. May, the challenge in regenerative medicine is no longer proving that these therapies work; it's making them scalable, affordable and accessible to patients worldwide. Read where the industry is headed next.
https://www.signalsblog.ca/why-i-helped-build-ccrm-a-journey-from-inspiration-to-impact/
CCRM | Commercializing Living Therapies CCRM brings together stakeholders, expertise, infrastructure and funding to accelerate the development and commercialization of regenerative medicines.
Click here to claim your Sponsored Listing.
Category
Telephone
Website
Address
661 University Avenue Suite 1002
Toronto, ON
M5G1M1
